Clinical Trials

ABILITY DIABETES GLOBAL Trial accepted in The Lancet

ABILITY DIABETES GLOBAL Trial accepted in The Lancet

-

CERC is proud to share that the ABILITY DIABETES GLOBAL Trial has been accepted for publication in The Lancet. Conducted under the leadership of Dr. Roxana Mehran, this study reflects a successful collaboration between Mount Sinai and CERC as CRO.